Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden
· Delayed Price · Currency is SEK 293.60
-1.40 (-0.47%)
May 28, 2025, 12:59 PM CET
STO:SOBI Revenue
Swedish Orphan Biovitrum AB had revenue of 6.47B SEK in the quarter ending March 31, 2025, with 3.34% growth. This brings the company's revenue in the last twelve months to 26.24B, up 13.38% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.
Revenue (ttm)
26.24B
Revenue Growth
+13.38%
P/S Ratio
3.84
Revenue / Employee
13.84M
Employees
1,806
Market Cap
100.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
| Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
| Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
| Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
| Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |
| Vitrolife AB | 3.61B |
Swedish Orphan Biovitrum AB News
- 6 days ago - Swedish Orphan Biovitrum: Haematology Focus Seems To Be Paying Off - Seeking Alpha
- 4 weeks ago - Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 2 months ago - Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum targets high single-digit growth in 2025 amid robust pipeline advancements - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Swedish Orphan Biovitrum AB (publ) 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire